June 12, 2017
CMIC HOLDINGS Co., Ltd.
Clinching Two Category Awards from Frost & Sullivan.
CMIC Co., Ltd., a consolidated subsidiary of CMIC HOLDINGS Co., Ltd., announced that the company has clinched the "2017 Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award". This will be the fourth consecutive year the company has received the CRO category award at the Asia Pacific Best Practices Awards Banquet . CMIC CMO Co., Ltd., the other subsidiary, also announced that the company received the "2017 Frost & Sullivan Japan CDMO Competitive Strategy Innovation and Leadership Award" prize at the Japan Excellence Awards for the first time.
The awards have identified and honored best-in-class companies that have demonstrated excellence in many industries or positioned as a leading company with competitiveness and customer base in the market.
The awards by Frost & Sullivan, a growth partnership company focused on research and consulting globally, recognizes remarkable companies in each field such as healthcare, environment, energy, IT, and security in the Asia Pacific region which expects to expand the market in the future.
CMIC Co., Ltd.
2017 Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award.
As the first CRO in Japan, the company has continuously provided services to reinforce the foundations of clients' businesses. Frost & Sullivan recognizes that the company grows its business by providing many services to promote the efficiency and acceleration of clinical trials and contributes to maximizing clients' corporate values.
CMIC CMO Co., Ltd.
2017 Frost & Sullivan Japan CDMO Competitive Strategy Innovation and Leadership Award.
CMIC Group is highly recognized for their full-range of functional service in non-clinical and clinical field, and utilizing of PVC(Pharmaceutical Value Creator) model with CDMO.
The CMIC Group will continuously utilize our abundant accumulated experience and knowledge to create new value in the field of healthcare.